Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression

Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies

(2015) Christos A. Goudis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)

(2014) Omid Fatemi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Diabetes Mellitus and Atrial Remodeling: Mechanisms and Potential Upstream Therapies

(2014) Qitong Zhang et al.   Cardiovascular Therapeutics

Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina

(2014) Li-Feng Hong et al.   Lipids in Health and Disease

Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation

(2014) Roopinder K. Sandhu et al.   Journal of the American Heart Association

Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

(2013) Roberto Latini et al.   AMERICAN HEART JOURNAL

Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century

(2013) Jocasta Ball et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)

(2012) Hiroyuki Daida et al.   Cardiovascular Diabetology

Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women

(2012) Tobias Schoen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus

(2012) Okan Turgut et al.   PLATELETS

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

(2011) Valentin Fuster et al.   CIRCULATION

An increased level of haemoglobin A1C predicts a poorer clinical outcome in patients with acute pancreatitis

(2011) Xiaolong Zhao et al.   CLINICAL ENDOCRINOLOGY

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

(2011) D. B. Sacks et al.   DIABETES CARE

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

(2011) Rachel R Huxley et al.   HEART

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

HbA1c and atrial fibrillation: A cross-sectional study in Japan

(2010) Yasuyuki Iguchi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation

(2010) Sascha Dublin et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects

(2008) Odd Johansen et al.   Cardiovascular Diabetology

Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery

(2008) Michael E. Halkos et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY